title: Image-derived biomarkers and multimodal imaging strategies for lung cancer management.
abstract: Non-small-cell lung cancer is the most common type of lung cancer and one of the leading causes of cancer-related death worldwide. For this reason, advances in diagnosis and treatment are urgently needed. With the introduction of new, highly innovative hybrid imaging technologies such as PET/CT, staging and therapy response monitoring in lung cancer patients have substantially evolved. In this review, we discuss the role of FDG PET/CT in the management of lung cancer patients and the importance of new emerging imaging technologies and radiotracer developments on the path to personalized medicine.
authors.affiliation: Diagnostic and Interventional Radiology, Department of Radiology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany.
authors.forename: Alexander W
authors.initials: AW
authors.lastname: Sauter
authors.forename: Nina
authors.initials: N
authors.lastname: Schwenzer
authors.forename: Mathew R
authors.initials: MR
authors.lastname: Divine
authors.forename: Bernd J
authors.initials: BJ
authors.lastname: Pichler
authors.forename: Christina
authors.initials: C
authors.lastname: Pfannenberg
mesh_terms: D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000000981:diagnostic imaging*; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging*; D008279:Magnetic Resonance Imaging; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals